Stay updated with breaking news from Lynn Baxter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dovato is a combination of dolutegravir, an integrase strand transfer inhibitor, and lamivudine, a nucleoside analogue reverse transcriptase inhibitor. The FDA has expanded the approval of Dovato (dolutegravir/lamivudine) to include treatment of HIV-1 infection in adolescents.
DURHAM, N.C.--(BUSINESS WIRE)--Apr 8, 2024--
The treatment is indicated for adolescents at least 12 years of age who weigh at least 25 kg without a previous treatment history of antiretroviral therapies.
Dovato is a combination of dolutegravir, an integrase strand transfer inhibitor, and lamivudine, a nucleoside analogue reverse transcriptase inhibitor. The FDA has expanded the approval of Dovato (dolutegravir/lamivudine) to include treatment of HIV-1 infection in adolescents.
21-year-old Cole Zelenco was on his second tour for the International Legion’s 92nd Mechanized Brigade when he was killed by Russian artillery on April 26, 2023, in Bakhmut, Ukraine